Clough Capital Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$644K Sell
6,000
-3,000
-33% -$322K 0.06% 96
2025
Q1
$908K Hold
9,000
0.11% 80
2024
Q4
$804K Hold
9,000
0.09% 93
2024
Q3
$754K Hold
9,000
0.08% 105
2024
Q2
$693K Hold
9,000
0.08% 101
2024
Q1
$616K Hold
9,000
0.07% 95
2023
Q4
$520K Hold
9,000
0.06% 133
2023
Q3
$475K Sell
9,000
-62,860
-87% -$3.32M 0.05% 134
2023
Q2
$3.89M Sell
71,860
-85,517
-54% -$4.63M 0.39% 76
2023
Q1
$7.87M Sell
157,377
-199,850
-56% -$10M 0.85% 40
2022
Q4
$16.5M Buy
357,227
+252,827
+242% +$11.7M 1.68% 14
2022
Q3
$4.04M Sell
104,400
-105,700
-50% -$4.09M 0.43% 37
2022
Q2
$7.83M Buy
210,100
+121,900
+138% +$4.54M 0.97% 31
2022
Q1
$3.91M Buy
+88,200
New +$3.91M 0.3% 71
2020
Q1
Sell
-258,946
Closed -$11.7M 129
2019
Q4
$11.7M Buy
258,946
+10,286
+4% +$465K 1% 40
2019
Q3
$10.1M Buy
248,660
+163,990
+194% +$6.67M 0.84% 33
2019
Q2
$3.64M Sell
84,670
-191,830
-69% -$8.24M 0.36% 71
2019
Q1
$10.6M Buy
276,500
+65,500
+31% +$2.51M 0.93% 36
2018
Q4
$7.46M Buy
211,000
+115,700
+121% +$4.09M 0.88% 41
2018
Q3
$3.67M Hold
95,300
0.35% 65
2018
Q2
$3.12M Hold
95,300
0.28% 73
2018
Q1
$2.6M Hold
95,300
0.25% 79
2017
Q4
$2.36M Sell
95,300
-162,100
-63% -$4.02M 0.2% 75
2017
Q3
$7.51M Hold
257,400
0.5% 54
2017
Q2
$7.14M Hold
257,400
0.5% 52
2017
Q1
$6.4M Sell
257,400
-23,825
-8% -$593K 0.41% 66
2016
Q4
$6.08M Buy
281,225
+257,700
+1,095% +$5.57M 0.4% 68
2016
Q3
$560K Sell
23,525
-160,925
-87% -$3.83M 0.03% 149
2016
Q2
$4.31M Buy
184,450
+8,500
+5% +$199K 0.23% 110
2016
Q1
$3.31M Buy
+175,950
New +$3.31M 0.16% 123
2013
Q4
Sell
-582,300
Closed -$6.84M 202
2013
Q3
$6.84M Sell
582,300
-362,300
-38% -$4.25M 0.21% 135
2013
Q2
$8.76M Buy
+944,600
New +$8.76M 0.29% 112